Moderna Surges On A Key Win For Its Merck-Partnered Cancer Vaccine In Europe
stock climbed Monday after European regulators granted its Merck (MRK)-partnered personalized cancer vaccine a key designation. X Under the prime scheme designation, the European Medicines Agency gives early feedback on test results to speed up the development and evaluation of medicines that may…#merck #keytruda #melanoma #stephenhoge #ericrubin #moderna #marketsmithcom #allisongatlin #ibdagatlin (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2023 Category: Consumer Health News Source Type: news
New therapy harnesses patients & #039; blood cells to fight tumors
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide a new treatment option to cancer patients, potentially bypassing radiation therapies and harsh chemotherapy drugs. (Source: World Pharma News)
Source: World Pharma News - April 10, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
New therapy harnesses patients' blood cells to fight tumors
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide a new treatment option to cancer patients, potentially bypassing radiation therapies and harsh chemotherapy drugs. (Source: World Pharma News)
Source: World Pharma News - April 10, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Update on IMBRUVICA ® (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications
HORSHAM, Pa., April 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics, an AbbVie Company, announced today the intent to voluntarily withdraw the U.S. indications for IMBRUVICA® (ibrutinib) for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, and for the treatment of patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. This decision was made in consultation with the U.S. Food and Drug Administration (FDA), c...
Source: Johnson and Johnson - April 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Six early warning signs of skin cancer revealed as Hugh Jackman reveals he may have it again
Hugh Jackman may have skin cancer again and is urging fans to stay vigilant. Dermatologists follow the ABCDEs when diagnosing melanoma: asymmetry, border, color, diameter, and evolution over time. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2023 Category: Consumer Health News Source Type: news
Risk for Melanoma Reduced for Individuals With Atopy
FRIDAY, March 31, 2023 -- Atopy is associated with a reduction in the risk for melanoma, according to a study published online Feb. 28 in Melanoma Research.
Jenni Komulainen, M.D., from the University of Eastern Finland in Kuopio, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2023 Category: Pharmaceuticals Source Type: news
Cancer-free and embracing new adventures thanks to Mayo's collaborative care
In January 2021, after being in remission from melanoma for almost a decade, Christina Armendariz began to feel unwell. The 42-year-old mother went to the emergency room at a hospital near her Orlando, Florida, home. After several imaging tests, Christina was told her cancer had returned. She had a mass under her arm and multiple soft tissue tumors throughout her body. Although she began treatment locally, Christina's condition worsened over time. She experienced significant cognitive… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 31, 2023 Category: Databases & Libraries Source Type: news
' Astounding' Response to Neoadjuvant Desmoplastic Melanoma Tx'Astounding' Response to Neoadjuvant Desmoplastic Melanoma Tx
Desmoplastic melanoma, an often deeply invasive disease occurring in older adults, showed a uniquely favorable response to neoadjuvant pembrolizumab in this small study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Candidate found to inhibit malignant melanoma growth
Malignant melanoma is a relatively aggressive type of skin cancer. When detected early, it is usually treatable by surgical resection only, but metastases develop often spreading to distant areas. Currently, tumor thickness and the presence of ulceration are some of the known prognostic factors used as indicators of malignant melanoma. Therefore, the discovery of valuable markers to assess the malignant potential of melanoma more accurately may be necessary to develop appropriate treatments. (Source: World Pharma News)
Source: World Pharma News - March 28, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
AAD: Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
MONDAY, March 27, 2023 -- Adults with atopic dermatitis (AD) have an increased risk for developing melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC), with significantly higher risks seen for moderate-to-severe versus mild AD,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 27, 2023 Category: Pharmaceuticals Source Type: news
Iovance Biotherapeutics completes license application submission for advanced melanoma therapy; shares rally
Biotech cancer-treatment developer Iovance Biotherapeutics Inc. IOVA, on Friday said it had completed its rolling biologics license application submission to the U.S. Food and Drug Administration for lifileucel — a therapy intended to combat advanced melanoma in some cases. Interim Chief Executive…#frederickvogt (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2023 Category: Consumer Health News Source Type: news
Best Shot First: Two ICIs Upfront for Advanced Melanoma Best Shot First: Two ICIs Upfront for Advanced Melanoma
With no biomarkers to say who can safely delay dual therapy, an editorialist said that two checkpoint inhibitors in the first line might be"prudent."Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 24, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
PET/CT shows promise in patients with IgG4-RD
F-18 FDG-PET/CT may be a valuable tool for identifying cardiovascular manifestation...Read more on AuntMinnie.comRelated Reading:
PET/CT reveals how COVID-19 manifests in critically ill patients
Can PET/CT scans replace bone biopsies in lymphoma patients?
PET/CT can influence management of colorectal cancer
PET/CT radiomics could help select patients for immunotherapy
PET/CT bests ultrasound for imaging malignant melanoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 22, 2023 Category: Radiology Source Type: news
A Pentagon Study Finds Higher Cancer Rates in Military Pilots and Ground Crews
WASHINGTON — A Pentagon study has found high rates of cancer among military pilots and for the first time has shown that ground crews who fuel, maintain and launch those aircraft are also getting sick.
The data had long been sought by retired military aviators who have raised alarms for years about the number of air and ground crew members they knew who had cancer. They were told that earlier military studies had found they were not at greater risk than the general U.S. population.
In its yearlong study of almost 900,000 service members who flew on or worked on military aircraft between 1992 and 2017, the Pentagon fo...
Source: TIME: Health - March 20, 2023 Category: Consumer Health News Authors: Tara Copp/AP Tags: Uncategorized Cancer healthscienceclimate wire Source Type: news
PET/CT reveals how COVID-19 manifests in critically ill patients
In a pictorial essay, Dutch researchers are highlighting findings from whole-bod...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT reveals sites of COVID-19 brain infection
Whole-body PET/CT cuts scan time in melanoma patients
NaF-PET shows bone formation in psoriatic arthritis patients
Whole-body PET/CT for a child: 5 minutes, no sedation
New PET/CT scanners may offer safer imaging in children (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 20, 2023 Category: Radiology Source Type: news
